Navient (NAVI) Beats Q3 Earnings on High Non-Interest Income

Wednesday, 18 October 2017 03:13 Written by

Navient Corporation’s (NAVI - Free Report) third-quarter 2017 core earnings per share (EPS) of 55 cents surpassed the Zacks Consensus Estimate of 50 cents.

IBM (IBM) Stock Pops On Q3 Cloud Revenue Growth

Tuesday, 17 October 2017 15:03 Written by

International Business Machines (IBM - Free Report) just released its third-quarter 2017 financial results, posting earnings of $3.30 per share and revenues of $19.15 billion.

Shares of Aerie Pharmaceuticals, Inc. (AERI - Free Report) have moved up 15.8% in the last one week on positive news for its lead drug, Rhopressa.

ImmunoGen to Push Leukemia Candidate into Phase I Trial

Tuesday, 17 October 2017 14:55 Written by

ImmunoGen, Inc. (IMGN - Free Report) announced that it is planning to move its leukemia candidate, IMGN632, into phase I study before the year-end.

Danaher Corporation (DHR - Free Report) is scheduled to report third-quarter 2017 results before the opening bell on Oct 19. In the quarter to be reported, the company is expected to report strong revenues in Life Sciences & Diagnostics business, which constitutes more than half of its total revenues.

Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall

Tuesday, 17 October 2017 14:44 Written by

Allergan plc (AGN - Free Report) announced that a Texas federal district court invalidated four of the six patents covering Restasis, Allergan’s second bestselling drug.